Multiscale quantum chemical approaches to QSAR modeling and drug design

被引:19
|
作者
De Benedetti, Pier G. [1 ]
Fanelli, Francesca [1 ]
机构
[1] Univ Modena & Reggio Emilia, Dept Life Sci, I-41125 Modena, Italy
关键词
QUANTITATIVE STRUCTURE-ACTIVITY; MOLECULAR-ORBITAL METHOD; CARBONIC-ANHYDRASE INHIBITORS; PROTEIN-COUPLED RECEPTORS; INITIO MO CALCULATIONS; COMPLEX STRUCTURES; BINDING-AFFINITY; THEORETICAL DESCRIPTORS; MECHANISTIC QSAR; LIGAND BINDING;
D O I
10.1016/j.drudis.2014.09.024
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The comparative use of classical, quantum chemical (QC) ligand-based (LB) and structure-based (SB) quantitative structure-activity relationship (QSAR) results in a detailed and mechanistic-causative description, at different scales (multiscale: classical = macroscopic, LB and SB = electronic-atomistic-nanoscale) and resolution levels, of the energetics and thermodynamics of the binding event for a congeneric set of ligands and/or drugs. QC interaction propensity (reactivity) descriptors in LB QSARs provide an implicitly more accurate estimation of the enthalpic contribution to ligand-target interactions compared with classical QSAR. As for QSAR models from ab initio SB fragment molecular orbital calculations, an explicit enthalpic description of the different additive terms in the computed binding energy is obtainable. Moreover, it is possible to estimate the difference in the free energy change of the ligand-target complex formation and evaluate, on a correlative basis, the contribution of each additive free energy term to the total value.
引用
收藏
页码:1921 / 1927
页数:7
相关论文
共 50 条
  • [21] QSAR -: a piece of drug design
    Pârvu, L
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2003, 7 (03): : 333 - 335
  • [22] QSAR - Application in Drug Design
    Malik, Jitender K.
    Soni, Himesh
    Singhai, A. K.
    Pandey, Harish
    INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH AND ALLIED SCIENCES, 2013, 2 (01): : 1 - 13
  • [23] Multivariate design and modeling in QSAR
    Eriksson, L
    Johansson, E
    CHEMOMETRICS AND INTELLIGENT LABORATORY SYSTEMS, 1996, 34 (01) : 1 - 19
  • [24] APPROACHES TO MODELING PROTEIN FLEXIBILITY DURING DRUG DESIGN
    Anderson, A.
    O'Neil, R.
    Lilien, R.
    Donald, B.
    Stroud, R.
    ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES, 2002, 58 : C89 - C89
  • [25] Systematic Generation of Chemical Structures for Rational Drug Design Based on QSAR Models
    Funatsu, Kimito
    Miyao, Tomoyuki
    Arakawa, Masamoto
    CURRENT COMPUTER-AIDED DRUG DESIGN, 2011, 7 (01) : 1 - 9
  • [26] Multiscale Quantum Refinement Approaches for Metalloproteins
    Yan, Zeyin
    Li, Xin
    Chung, Lung Wa
    JOURNAL OF CHEMICAL THEORY AND COMPUTATION, 2021, 17 (06) : 3783 - 3796
  • [27] MODELING CHEMICAL REACTIONS IN DRUG DESIGN AND CHEMICAL RISK ASSESSMENT
    Gasteiger, Johann
    MEDICINAL CHEMISTRY RESEARCH, 2010, 19 : S16 - S17
  • [28] QSARtuna: An Automated QSAR Modeling Platform for Molecular Property Prediction in Drug Design
    Mervin, Lewis
    Voronov, Alexey
    Kabeshov, Mikhail
    Engkvist, Ola
    JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2024, 64 (14) : 5365 - 5374
  • [29] COMPARISON OF 2 RELATED APPROACHES TO MODELING IN QSAR
    HYDE, R
    LORD, E
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 1979, 14 (03) : 199 - 202
  • [30] QSAR Modeling and Prediction of Drug-Drug Interactions
    Zakharov, Alexey V.
    Varlamova, Ekaterina V.
    Lagunin, Alexey A.
    Dmitriev, Alexander V.
    Muratov, Eugene N.
    Fourches, Denis
    Kuz'min, Victor E.
    Poroikov, Vladimir V.
    Tropsha, Alexander
    Nicklaus, Marc C.
    MOLECULAR PHARMACEUTICS, 2016, 13 (02) : 545 - 556